Efficacy and Safety of GTx-024 in Patients With Estrogen Receptor (ER)+/Androgen Receptor (AR)+ Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: ER+ and AR+ Breast Cancer
Interventions: DRUG: GTx-024
Sponsor: GTx